FindTrial
Sign In

Study of incidence, resistance patterns, efficacy of ceftazidime-avibactam and aztreonam in critically ill patients with carbapenem resistant enterobacterales (CRE) infection in a tertiary care setup- A prospective observational study

Study of incidence, resistance patterns, efficacy of ceftazidime-avibactam and aztreonam in critically ill patients with carbapenem resistant enterobacterales (CRE) infection in a tertiary care setup- A prospective observational study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091845
Enrollment
84
Registered
2025-07-28
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B961- Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

BLK MAX SUPERSPECIALITY OSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ?18 years

Exclusion criteria

Exclusion criteria: PREGNANT PATIENTS PATIENT UNLIKELY TO SURVIVE BEYOND 48 HOUR CANCER DIAGNOSIS IMMUNOSUPPRESSIVE/ANTI CANCER THERAPY

Design outcomes

Primary

MeasureTime frame
TO FIND THE INCIDENCE OF CRE INFECTION AND 28 DAY MORTALITY IN ADULT PATIENTS ADMITTED IN MICUTimepoint: TO FIND THE INCIDENCE OF CRE INFECTION AND 28 DAY MORTALITY IN ADULT PATIENTS ADMITTED IN MICU—

Secondary

MeasureTime frame
TO STUDY THE TIME TO MICROBIOLOGICAL AND CLINICAL CURE IN ADULT PATIENTS WITH CRE IN ICUTimepoint: ;TO STUDY THE RISK FACTORS, ANTIBIOTIC SUSCEPTIBILITY AND RESISTANCE PATTERN (MIC VALUE AND BREAK POINTS) IN ADULT PATIENTS WITH CRE IN ICUTimepoint: ;TO STUDY THE FOLLOWING synergy between CAZ-AVI+ATM number of ventilator days days on renal replacement therapy ICU length of staysTimepoint:—

Countries

India

Contacts

Public Contactpriyanka sagar

BLK MAX SUPERSPECIALITY HOSPITAL

96priyankasagar@gmail.com9971498506

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026